Pharma Tycoon Dilip Shanghvi, founder and managing director of Indian pharma Sun Pharmaceuticals, has overtakes Mukesh Ambani as the country’s richest man, according to calculations based on the market value of their shareholdings.
Sun Pharmas Dilip Shanghvi, who has holds than 63% in three pharmaceutical companies — Sun Pharma, Ranbaxy Labs and Sun Pharma Advanced Research— is worth about $23.42bn as of 19 February, 2015. According the Times of India’s calculations based on data from the Bombay Stock Exchange.
Meanwhile, Mukesh Ambani’s networth is $21.2bn based on his 45% holdings in Reliance Industries and Reliance Industrial Infrastructure.
Sun Pharma’s Dilip Shanghvi’s networth would be even higher at $23.7bn, if we take into account the 23% stake that he and his family are set to acquire.
However, Ambani is still the richest Indian with a net worth of $21.9bn, according to the Bloomberg billionaire index. He is also the 33rd richest person in the world.
Shanghvi is the second richest Indian valued at $19.6bn, according to Bloomberg. He is also ranked number 39 among global billionaires.
According to Forbes, Ambani and Shanghvi are richest Indians with fortunes of $23.6bn and $18bn, respectively.
This post has been seen 642 times.